ORTHO CLINICAL DIAGNOSTICS H's ticker is OCDX and the CUSIP is G6829J107. A total of 174 filers reported holding ORTHO CLINICAL DIAGNOSTICS H in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $83,525,000 | -51.6% | 4,476,193 | -44.5% | 0.04% | -44.4% |
| Q4 2021 | $172,586,000 | +13.4% | 8,068,533 | -2.1% | 0.07% | +7.5% |
| Q3 2021 | $152,238,000 | +11.7% | 8,238,086 | +29.4% | 0.07% | +15.5% |
| Q2 2021 | $136,273,000 | -0.3% | 6,364,925 | -10.2% | 0.06% | -6.5% |
| Q1 2021 | $136,726,000 | – | 7,086,087 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carlyle Group Inc. | 118,106,000 | $2,182,599,000 | 17.27% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 6,715,631 | $124,105,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 1,118,170 | $20,664,000 | 1.72% |
| Pinz Capital Management, LP | 180,200 | $3,330,000 | 1.51% |
| Eversept Partners, LP | 914,986 | $16,908,941 | 1.17% |
| CRAMER ROSENTHAL MCGLYNN LLC | 1,824,000 | $33,708,000 | 1.15% |
| Avidity Partners Management LP | 2,398,000 | $44,315,000 | 0.98% |
| ARMISTICE CAPITAL, LLC | 2,300,000 | $42,504,000 | 0.72% |
| Alyeska Investment Group, L.P. | 3,032,329 | $56,037,000 | 0.69% |
| Monashee Investment Management LLC | 180,000 | $3,326,000 | 0.61% |